BioTelemetry, Inc. to Release Third Quarter 2020 Earnings Results on October 29, 2020
BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2020 earnings on October 29 at 4:00 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2020 earnings on October 29 at 4:00 PM ET. Following this, an earnings conference call will take place at 5:00 PM ET, which will be available via webcast on the investor relations page of their website.
BioTelemetry specializes in remote medical technology, offering services that enhance health information accessibility and lower care costs. Their solutions include remote cardiac monitoring and clinical trial laboratory services.
Positive
- Upcoming earnings call allowing investor engagement.
- Strong focus on remote medical technology, indicating growth potential.
Negative
- None.
Details
News Market Reaction – BEAT
The recorded move for BEAT in the trading session of this news was +3.13%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MALVERN, Pa., Oct. 22, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2020 earnings on Thursday, October 29 at 4:00 PM Eastern Time.
BioTelemetry, Inc. will host an earnings conference call on Thursday, October 29, at 5:00 PM Eastern Time. The call will be webcast on the investor information page of our website, investors.gobio.com. The call will be archived on our website for at least two weeks.
About BioTelemetry
BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care. We provide remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring and original equipment manufacturing that serves both healthcare and clinical research customers. More information can be found at www.gobio.com.
| Contact: | BioTelemetry, Inc. |
| Heather C. Getz | |
| Investor Relations | |
| Executive Vice President, Chief Financial Officer | |
| 800-908-7103 | |
| InvestorRelations@biotelinc.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.